More and more doctors who are diagnosing healthy patients with Cancer in order to make a profit from poisonous chemotherapy and cancer drugs are being caught by authorities.
A worrying amount of doctors have been misrepresenting their oaths by misdiagnosing cancer to otherwise healthy patients in order to make a profit from prescribing cancer drugs.
It’s becoming more apparent that Big Pharma has used terminal illnesses to make a profit from the seemingly lucrative cancer drug industry.
It is no wonder why fraudulent doctors would jump at this opportunity to make a quick buck.
One well-known example is a Dr. Farid Fata: an infamous cancer doctor in Michigan who admitted in court to deliberately diagnosing healthy people with cancer.
Fata ran a $35-million Medicare fraud scheme that involved diagnosing healthy people with cancer and ruining countless lives in order to make a profit from cancer drugs.
“Many of these unscrupulous Physicians are like businessmen without a conscience. The only difference is they have your health and trust in their hands–a very dangerous combination when money is involved,” said Dr. Sayed Mohammed, a retired Oncologist who saw the trend more 10 years ago.
This is what Dr. Fata said in court in his guilty plea:
“It is my choice,”
“I knew that it was medically unnecessary.”
The federal government mentions Fata ran the plan from 2009 to today, through his medical organizations, consisting of Michigan Hematology Oncology Centers, with workplaces in Clarkston, Bloomfield Hills, Lapeer, Sterling Heights, Troy, and Oak Park.
Cancer Drugs are a money making machine
According to the federal government, Fata had a patient load of 1,200 individuals and received $62 million from Medicare for cancer drugs he billed for more than $150 million.U.S.
Lawyer Barbara McQuade stated she wanted for life in prison for Fata, calling his case is “the most outright” health care rip-offs case the health industry has ever seen.
She stated Fata not just conned the government, which prevails in such cases, but he also damaged many people’s health.
Lying with Statistics
Prostate cancer is another fantastic example which physicians mistakenly use diagnoses about without offering customers the truths.
A prostate (PSA) blood test searches for prostate-specific antigen, a protein produced by the prostate gland.
High levels are related to prostate cancer.
The concern is that the association isn’t always correct when it is, the prostate cancer isn’t still fatal.
Only about 3 percent of all males pass away from prostate cancer.
The PSA test generally results in overdiagnosis, biopsies, and treatment in which the negative results are impotence and incontinence.
Recurring biopsies may spread out cancer cells into the track formed by the needle, or by spilling malignant cells straight into the bloodstream or lymphatic system.
It shows harmful and typically deadly in the long run for many individuals who do not comprehend the very best ways to take care of their health and are encouraged by incorrect stats.
Lots of excellent significant research studies have been done on males who have in fact had cancer found in their prostate with a biopsy.
In over 97% of the cases this cancer either never expands beyond the gland to trigger damage or the customer dies of something else long before any evidence of cancer spreading outside of the prostate takes place.
Since 3% where cancer is aggressive and harms the client, it has currently spread beyond the limits of surgical resection long formerly discovery; thus, these males are not helped by surgical treatment either.
After a minimum of seven years of post-college graduate medical education on the psychological, psychological, and physical condition of the person, you would anticipate a doctor to be a powerhouse of goodwill for his/her clients.
Regretfully, a lot of physicians fail to keep the well-being of their customers at the leading edge, as their primary issue.
They have to enhance their egos, self-preservation, and the objective for more money typically cause improper care and harm to the client.
Many women are usually notified that hysterectomies result in numerous treatments for this disease and other conditions.
This is misrepresenting the truth.
Breast cancer screenings likewise cause a boost in breast cancer mortality and fail to deal with prevention. Regardless of no proof ever having really supported any recommendations made for routine periodic screening and mammography at any age, malicious suggestions from the Society of Breast Imaging (SBI)
The American College of Radiology (ACR) on breast cancer screening are now suggesting that breast cancer screening ought to start at age 40 and earlier in high-risk clients
Launched in the Journal of the American College of Radiology (JACR), the suggestions launched by the SBI and ACR state that the typical customer ought to start yearly breast cancer screening at age 40.
They also target females in their 30s if they are considered “high threat” as they specified.
The rate of innovative breast cancer for U.S. women 25 to 39 years of ages almost doubled from 1976 to 2009, a distinction undue to be a matter of chance and more about medical diagnoses.
A troubling research study released in the New England Journal of Medicine is bringing mainstream concentrate on that mammography has activated a lot more damage than high in the many women who have employed it over the past 30 years as their primary technique in the fight versus breast cancer.
Chemotherapy Does Not Heal The Body, It Slowly Destroys It
Chemotherapy boosts cancer development and long-term death rates. Most chemotherapy patients either die or are afflicted with the disease within 10-15 years after treatment.
It ruins their immune system, increases neuro-cognitive decrease, interrupts endocrine working and triggers organ and metabolic toxicities.
Clients live in an irreversible state of the disease until their death.
The cancer market marginalizes safe and effective cures while promoting their patented, expensive, and harmful solutions whose dangers far exceed any benefit.
This is exactly what they do best, and they do it because it generates income, plain and simple.
The factor a 5-year relative survival rate is the basis used to evaluate mortality rates is because of most cancer patients going downhill after this period
It’s awful for an organization and the cancer industry understands it.
They might never reveal the public the true 97% analytical failure rate in dealing with long-term metastatic cancers.